| Required output | Provisional content |
|---|---|
| 1. Executive judgment | **Partially supported (provisional).** Seed evidence is consistent with biallelic or damaging **SYCE1** variants causing meiotic failure via synaptonemal-complex dysfunction, but the strength of support cannot be fully graded here because the papers were not retrievable in this run; **manual verification required** (PMIDs: 25062452, 32402064, 34718620, 35718780). |
| 2. Evidence matrix | The current evidence spans human familial genetics, a mouse/model study, in vitro interaction/SC assembly assays, and human male histology with NOA, which together cover most steps of the proposed mechanism; however, assay details, sample sizes, and directness of each claim need full-text confirmation; **manual verification required** (PMIDs: 25062452, 32402064, 34718620, 35718780). |
| 3. Clinical spectrum summary | In 46,XX individuals, seed evidence indicates **primary ovarian insufficiency/primary amenorrhea**; in 46,XY individuals, seed evidence indicates **non-obstructive azoospermia with pachytene-stage spermatogenic arrest** on H&E/IF. Specific hormone values, ovarian imaging, and biopsy markers are not available from the retrieved tool output; **manual verification required** (PMIDs: 25062452, 35718780). |
| 4. Variant and inheritance summary | The seed claims support an **autosomal recessive / biallelic** disease model, including a **homozygous nonsense variant c.613C>T**, additional damaging variants, and **SYCE1 CNVs**. Exact zygosity/phasing for all reported variants and family counts remain to be confirmed from full text; **manual verification required** (PMIDs: 25062452, 34718620, 35718780). |
| 5. Mechanistic causal chain | Provisional chain: **biallelic SYCE1 loss/damaging variant -> reduced/absent SYCE1 -> disrupted interaction with SYCP1 and/or C14ORF39/SIX6OS1 -> synaptonemal-complex central element assembly failure -> homologous synapsis failure -> pachytene arrest/checkpoint activation -> germ-cell depletion -> POI or NOA**. Human support appears strongest for the phenotype and arrest endpoints, with intermediate steps partly inferred from model/in vitro work; **manual verification required** (PMIDs: 32402064, 34718620, 35718780). |
| 6. Diagnostics and management implications | Provisional implications include adding **SYCE1** to infertility/POI/NOA gene panels with CNV detection, considering semen analysis and testicular biopsy in 46,XY cases, and endocrine/ovarian reserve evaluation in 46,XX cases. Management likely follows standard POI and NOA care pathways, but disorder-specific outcomes such as micro-TESE yield are not verified here; **manual verification required** (PMIDs: 25062452, 35718780). |
| 7. Ontology suggestions | Likely relevant labels include **Primary ovarian insufficiency, Primary amenorrhea, Non-obstructive azoospermia, Spermatogenic arrest, Synaptonemal complex assembly, Homologous chromosome pairing, Pachytene spermatocyte, Germ cell**, and related treatment/action terms. These are ontology leads rather than evidence-verified annotations from the blocked retrieval run; **manual verification required** (PMIDs: 25062452, 32402064, 34718620, 35718780). |
| 8. Knowledge gaps and weak claims | The main gaps are the absence of retrievable full texts, lack of confirmed 2023-2024 updates, limited direct human evidence for **checkpoint activation/apoptosis**, and incomplete verification of endocrine/histologic details and CNV inheritance. Several mechanistic links are therefore stronger in model/in vitro systems than in directly observed human tissue; **manual verification required** (PMIDs: 32402064, 34718620, 35718780). |
| 9. Curation leads | Candidate updates for the entry are: annotate **biallelic SYCE1 loss-of-function/CNV disease mechanism**, note **SC central element interaction defects with SYCP1 and C14ORF39/SIX6OS1**, and capture the dual-sex phenotype of **46,XX POI/primary amenorrhea** and **46,XY NOA/pachytene arrest**. These should remain provisional until the seed manuscripts and any newer cohorts are manually reviewed; **manual verification required** (PMIDs: 25062452, 32402064, 34718620, 35718780). |


*Table: This table compactly maps the nine requested report outputs to provisional seed-based conclusions for SYCE1-related gametogenic failure. It is useful as an embed-ready summary while clearly marking all items as requiring manual verification from the cited seed PMIDs.*